Merck & Co. (MRK)

Operating Expenses

$38.99B

TTM · Period ending: · USD

MRK logo

MRK Operating Expenses

Latest reported$38.99B
MRK TTM Operating Expenses ($3.09B → $38.99B)
High-resolution chart · PNG

MRK operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Merck & Co. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
38,994,000,000
31,693,000,000
21,491,000,000
23,592,000,000
26,659,000,000
27,304,000,000
28,755,000,000
33,738,000,000
30,971,000,000
40,755,000,000
41,035,000,000
35,066,000,000
36,159,000,000
25,446,000,000
23,590,000,000
23,026,000,000
20,888,000,000
22,180,000,000
21,880,000,000
24,904,000,000
25,532,000,000
23,100,000,000
23,265,000,000
19,780,000,000
20,164,000,000
20,895,000,000
20,487,000,000
19,907,000,000
18,625,000,000
18,506,000,000
19,854,000,000
19,857,000,000
22,218,000,000
21,718,000,000
20,316,000,000
22,698,000,000
19,883,000,000
20,210,000,000
19,885,000,000
17,056,000,000
16,971,000,000
16,656,000,000
17,017,000,000
17,812,000,000
18,474,000,000
18,817,000,000
18,787,000,000
18,396,000,000
18,225,000,000
18,829,000,000
19,415,000,000
20,212,000,000
20,730,000,000
20,903,000,000
20,945,000,000
21,454,000,000
21,767,000,000
21,759,000,000
22,145,000,000
24,117,200,000
24,337,200,000
24,285,200,000
24,236,200,000
21,567,700,000
19,033,200,000
16,804,000,000
14,388,100,000
12,210,000,000
12,131,900,000
12,106,600,000
12,182,200,000
12,034,900,000
12,525,400,000
12,540,100,000
12,439,400,000
13,406,900,000
13,331,000,000
13,123,300,000
12,948,300,000
12,037,200,000
11,405,000,000
11,200,600,000
10,995,700,000
11,312,400,000
11,300,800,000
11,200,900,000
11,356,500,000
10,607,600,000
10,175,500,000
9,986,500,000
9,734,700,000
9,580,900,000
9,455,200,000
9,202,000,000
8,892,600,000
8,678,000,000
8,762,900,000
8,923,200,000
9,010,900,000
9,725,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.